| Literature DB >> 31383914 |
Kasper Pryds1,2,3, Anders Hostrup Larsen4,5, Mona Sahlholdt Hansen4,5, Anne Yoon Krogh Grøndal6, Rasmus Stilling Tougaard4,5, Nils Henrik Hansson4, Tor Skibsted Clemmensen4, Brian Bridal Løgstrup4, Henrik Wiggers4, Won Yong Kim4, Hans Erik Bøtker4, Roni Ranghøj Nielsen4,5.
Abstract
Myocardial deformation assessed by speckle tracking echocardiography (STE) is increasingly used for diagnosis, monitoring and prognosis in patients with clinical and pre-clinical cardiovascular diseases. Feature tracking cardiac magnetic resonance (FT-CMR) also allows myocardial deformation analysis. To clarify whether the two modalities can be used interchangeably, we compared myocardial deformation analysis by FT-CMR with STE in patients with a variety of cardiovascular diseases and healthy subjects. We included 40 patients and 10 healthy subjects undergoing cardiac magnetic resonance and echocardiographic examination for left ventricular volumetric assessment. We studied patients with heart failure and reduced ejection fraction (n = 10), acute perimyocarditis (n = 10), aortic valve stenosis (n = 10), and previous heart transplantation (n = 10) by global longitudinal (GLS), radial (GRS) and circumferential strain (GCS). Myocardial deformation analysis by FT-CMR was feasible in all but one participant. While GLS, GRS and GCS measured by FT-CMR correlated overall with STE (r = 0.74 and p < 0.001, r = 0.58 and p < 0.001, and r = 0.76 and p < 0.001), the correlations were not consistent within subgroups. GLS was systematically lower, whereas GRS and GCS were higher by FT-CMR compared to STE (p = 0.04 and p < 0.0001). Inter- and intra-observer reproducibility were comparable for FT-CMR and STE overall and across subgroups. In conclusion, myocardial deformation can be evaluated using FT-CMR applied to routine cine-CMR images in patients with a variety of cardiovascular diseases. However, correlation between FT-CMR and STE was modest and agreement was not optimal due to systematic bias regarding GLS and GCS. Consequently, FT-CMR and STE should not be used interchangeably for myocardial strain evaluation.Entities:
Mesh:
Year: 2019 PMID: 31383914 PMCID: PMC6683180 DOI: 10.1038/s41598-019-47775-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline characteristics.
| Healthy subjects | HF | Peri-myocarditis | AVS | HTX | p-value | |
|---|---|---|---|---|---|---|
| (n = 10) | (n = 10) | (n = 10) | (n = 10) | (n = 10) | ||
| Age (years) | 63.1 ± 4.4 | 67.9 ± 5.0 | 29.7 ± 12.6 | 71.1 ± 8.7 | 54.0 ± 10.3 | 0.0001 |
| Men | 7 (70%) | 10 (100%) | 6 (60%) | 5 (50%) | 8 (80%) | 0.11 |
| Body mass index (kg/meter2) | 25.9 ± 4.0 | 28.9 ± 5.1 | 24.8 ± 2.4 | 25.3 ± 4.3 | 26.2 ± 3.9 | 0.20 |
| Comorbidity: | ||||||
| Hypertension | 0 (0%) | 3 (30%) | 0 (0%) | 4 (40%) | 8 (80%) | <0.001 |
| Atrial fibrillation | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | — |
| Previous acute myocardial infarction | 0 (0%) | 8 (80%) | 0 (0%) | 0 (0%) | 0 (0%) | <0.001 |
| Medical treatment: | ||||||
| Beta-blockers | 0 (0%) | 10 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | <0.001 |
| ACE-I/ARB | 0 (0%) | 10 (100%) | 0 (0%) | 0 (0%) | 4 (40%) | <0.001 |
| Cardiac device therapy* | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | — |
| Biochemical and hemodynamic parameters: | ||||||
| eGFR >90 (ml/min/1.73 m2) | 10 (100%) | 5 (50%) | 6 (60%) | 5 (50%) | 2 (20%) | 0.005 |
| LVEF (%) | 65.9 ± 3.3 | 42.2 ± 5.8 | 56.9 ± 14.4 | 66.6 ± 19.7 | 66.4 ± 14.8 | 0.001 |
Data are mean ± SD or absolute numbers (%). HF, heart failure; AVS, Aortic valve stenosis; HTX, heart transplant; ACE-I, Angiotensin-converting enzyme inhibitor; ARB, Angiotensin II receptor blockers; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction.
*Bradypacemaker, Cardiac resynchronization therapy or implantable cardiac defibrillator.
Figure 1Myocardial strain assessment by FT-CMR and STE. Illustration depicting myocardial segmentation and data analysis for global longitudinal strain evaluation using feature tracking cardiac magnetic resonance imaging (A) and 2-D speckle tracking echocardiography (B). See text for details. 4CH, Four-chamber view; 2CH, Two-chamber view; 3CH, Three-chamber view; SAX, Short-axis view.
Figure 2Myocardial strain evaluation using FT-CMR vs. STE. FT-CMR, Feature tracking cardiac magnetic resonance; STE, speckle tracking echocardiography; GLS, Global longitudinal strain; GRS, Global radial strain; GCS, Global circumferential strain; BA, Bland-Altman; LOA, 95% limits of agreements (mean ± 1.96*standard deviation).
Myocardial strain evaluation using FT-CMR vs. STE.
| Difference | |||||
|---|---|---|---|---|---|
| FT-CMR | STE | Absolute | 95% CI | ||
| All participants | |||||
| GLS (n = 50) | 12.5 ± 3.1 | 15.6 ± 4.3 | −3.1 ± 2.9 | −3.9 to −2.3 | <0.0001 |
| GRS (n = 39) | 34.8 ± 14.5 | 30.6 ± 12.0 | 4.2 ± 12.3 | 0.2 to 8.2 | 0.04 |
| GCS (n = 39) | 18.3 ± 6.4 | 14.2 ± 4.8 | 4.1 ± 4.2 | 2.8 to 5.5 | <0.0001 |
| GLS (n = 50) | 1.0 | 2.9 | 2.7 | 0.74 | <0.001 |
| GRS (n = 39) | 0.5 | 9.7 | 14.2 | 0.58 | <0.001 |
| GCS (n = 39) | 0.6 | 3.2 | 3.8 | 0.76 | <0.001 |
Data are mean ± SD or absolute numbers.
FT-CMR, Feature tracking cardiac magnetic resonance; STE, speckle tracking echocardiography; CI, confidence interval; SEE, Standard error of estimate; GLS, Global longitudinal strain; GRS, Global radial strain; GCS, Global circumferential strain.
Intra-observer and inter-observer reproducibility for myocardial strain evaluation using FT-CMR and STE.
| Intra-observer | Inter-observer | |||||
|---|---|---|---|---|---|---|
| SEE | CV (%) | ICC | SEE | CV (%) | ICC | |
| Overall | ||||||
| GLS | 0.5 (n = 50) | 4.2 (n = 50) | 0.99 (n = 50) | 1.2 (n = 49) | 9.1 (n = 49) | 0.95 (n = 49) |
| GRS | 4.5 (n = 50) | 12.8 (n = 50) | 0.98 (n = 50) | 4.7 (n = 50) | 20.2 (n = 50) | 0.84 (n = 50) |
| GCS | 1.3 (n = 50) | 6.8 (n = 50) | 0.99 (n = 50) | 2.2 (n = 50) | 13.1 (n = 50) | 0.94 (n = 50) |
| Overall | ||||||
| GLS | 0.6 (n = 50) | 4.2 (n = 50) | 0.99 (n = 50) | 1.5 (n = 50) | 9.5 (n = 50) | 0.97 (n = 50) |
| GRS | 4.2 (n = 39) | 15.1 (n = 39) | 0.96 (n = 39) | 8.1 (n = 33) | 26.7 (n = 33) | 0.88 (n = 33) |
| GCS | 0.9 (n = 39) | 6.3 (n = 39) | 0.99 (n = 39) | 2.2 (n = 33) | 16.9 (n = 33) | 0.93 (n = 33) |
Data are absolute numbers.
FT-CMR, Feature tracking cardiac magnetic resonance; STE, speckle tracking echocardiography; SEE, Standard error of estimate; CV, coefficient of variation; ICC, Intraclass correlation coefficient; GLS, Global longitudinal strain; GRS, Global radial strain; GCS, Global circumferential strain.